Cargando…

Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review

BACKGROUND: (18)F-Fluoro-Deoxy-Glucose Positron Emission Tomography with Computed Tomography ((18)F-FDG PET/CT) may be a powerful tool to predict treatment outcome. We aimed to review the effectiveness of (18)F-FDG PET/CT in the assessment of early response to induction chemotherapy (IC) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Anjos, Renata Fockink, dos Anjos, Dalton Alexandre, Vieira, Danielle Leal, Leite, André Ferreira, Figueiredo, Paulo Tadeu de Souza, de Melo, Nilce Santos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985316/ https://www.ncbi.nlm.nih.gov/pubmed/27512861 http://dx.doi.org/10.1097/MD.0000000000004450

Ejemplares similares

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Application of whole-body FDG-PET for cancer screening in a cohort of hospital employees
por: Hu, Chin, et al.
Publicado: (2016)

Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer
por: Im, Hyung-Jun, et al.
Publicado: (2016)

Baseline SUVmax of (18)F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma
por: Xia, Xianwu, et al.
Publicado: (2020)

Diagnostic accuracy of (18)F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer
por: Choi, Byung Wook, et al.
Publicado: (2016)

Burkitt lymphoma and cavernous sinus syndrome with breast uptake on (18)F-FDG-PET/CT: A case report
por: Reyneke, Florette, et al.
Publicado: (2017)

Glucose metabolism of visceral adipose tissue measured by (18)F-FDG PET/CT is related to the presence of colonic adenoma
por: Yoon, Hai-Jeon, et al.
Publicado: (2017)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Imaging Findings of Bisphosphonate-Related Osteonecrosis of the Jaws: A Critical Review of the Quantitative Studies
por: Leite, André Ferreira, et al.
Publicado: (2014)

Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session
por: Oh, Dongryul, et al.
Publicado: (2016)

Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population
por: Naganawa, Shotaro, et al.
Publicado: (2017)

(18)F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report
por: Shen, Xun-Ze, et al.
Publicado: (2021)

Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
por: Zhang, Wen-Qian, et al.
Publicado: (2015)

Prognostic value of (18)F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis
por: Chen, Linyan, et al.
Publicado: (2017)

FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study
por: Lawal, Ismaheel O., et al.
Publicado: (2020)

Bone metastases with “false negative” findings on (18)F-FDG PET/CT in patients with angiosarcoma: A case series with literature review
por: Ariga, Akane, et al.
Publicado: (2023)

Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by (18)F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer
por: Song, Bong-Il, et al.
Publicado: (2015)

Predictive Value of (18)F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer
por: Ko, Kai-Hsiung, et al.
Publicado: (2015)

Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on (18)F-FDG PET/CT: A case report
por: Hu, Yan, et al.
Publicado: (2018)

Comparison of different automated lesion delineation methods for metabolic tumor volume of (18)F-FDG PET/CT in patients with stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Necrosis on pre-radiotherapy (18)F-FDG PET/CT is a predictor for complete metabolic response in patients with non-small cell lung cancer
por: Eren, Gülnihan, et al.
Publicado: (2022)

Prognostic significance of volume-based (18)F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma
por: Wang, Dalong, et al.
Publicado: (2021)

Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT
por: Pan, Yi, et al.
Publicado: (2015)

Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan
por: Chen, Jin-Hua, et al.
Publicado: (2016)

The Value of (18)F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Luo, Jurui, et al.
Publicado: (2016)

Percentage change of primary tumor on (18)F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI
por: Yoo, Jang, et al.
Publicado: (2017)

Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma
por: Qi, Cheng-Lin, et al.
Publicado: (2021)

Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study
por: Nicolau, Ulisses Ribaldo, et al.
Publicado: (2018)

(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
por: Guan, Jian, et al.
Publicado: (2016)

Overexpression of fatty acid desaturase 3 predicts poor prognosis in head and neck squamous cell carcinoma
por: Su, Kuiwei, et al.
Publicado: (2022)

Involvement of KLRK1 in immune infiltration of head and neck squamous cell carcinoma correlates with favorable prognosis
por: Tan, Haosheng, et al.
Publicado: (2023)

Hypoxia with (18)F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography ((18)F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome
por: Hu, Man, et al.
Publicado: (2019)

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by (18)fluorocholine PET/CT and its comparison with (68)gallium-DOTATOC PET/CT: Case report and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2017)

Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma
por: Li, Juanjuan, et al.
Publicado: (2023)

Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes
por: Zhang, Aichun, et al.
Publicado: (2023)

Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis
por: Tang, Wen-Hua, et al.
Publicado: (2020)

Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection
por: Jeong, Eugene, et al.
Publicado: (2017)

IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis
por: Li, Hongxiang, et al.
Publicado: (2023)

Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma
por: Shi, Yujing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2l4hmjh5q2s7ce3mf9prj89gfr